PR Newswire
LONDON, United Kingdom, January 30
Tetragon Financial Group LimitedDecember 2025 Monthly Factsheet
LONDON,Jan. 30, 2026/PRNewswire/ — Tetragon has released its MonthlyFactsheet
for December 2025.
· Net Asset Value: $3,892m
· Fully Diluted NAV per Share: $41.88
· Share Price (TFG NA): $17.35
· Monthly NAV per Share Total Return: 0.1%
· Monthly Return on Equity: 0.5%
· Most Recent Quarterly Dividend: $0.11
· Dividend Yield: 2.6%
Please refer to important disclosures on page three of the Monthly Factsheet.
Please click below to access the Monthly Factsheet.
December 2025 Factsheet (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4606370
-1&h=465948995&u=https%3A%2F%2Fwww.tetragoninv.com%2Fwp
-content%2Fuploads%2F2026%2F01%2Fmonthly-factsheet-dec
-2025.pdf&a=December+2025+Factsheet)
About Tetragon:
Tetragon is a Guernsey closed-ended investment company. Its non-voting shares
are listed on Euronext in Amsterdam, a regulated market of Euronext Amsterdam
N.V., and also traded on the Specialist Fund Segment of the Main Market of the
London Stock Exchange. Our investment manager is Tetragon Financial Management
LP. Find out more
atwww.tetragoninv.com (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4606370
-1&h=3312890386&u=http%3A%2F%2Fwww.tetragoninv.com%2F&a=www.tetragoninv.com).
Tetragon’s non-voting shares are subject to restrictions on ownership by U.S.
persons and are not intended for European retail investors.
Please see:https://www.tetragoninv.com/shareholders/additional
-information (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4606370
-1&h=2213102989&u=https%3A%2F%2Fwww.tetragoninv.com%2Fshareholders%2Fadditional
-information&a=https%3A%2F%2Fwww.tetragoninv.com%2Fshareholders%2Fadditional
-information).
Tetragon Investor Relations:
Yuko Thomas
[email protected]
Press Inquiries:
Prosek Partners
[email protected]
U.K. +44 20 3890 9193
U.S. +1 212 279 3115
Thisrelease doesnotcontain or constitute an offer to sellor a solicitation of an
offer to purchase securitiesin the United Statesor any other jurisdiction. The
securities of Tetragon have not been and will not be registered under the U.S.
Securities Act of 1933 and may not be offered or sold in the United States or to
U.S. persons unless they are registered under applicable law or exempt from
registration. Tetragon does not intend to register any portion of its securities
in the United States or to conduct a public offer of securities in the United
States. In addition, Tetragon has not been and will not be registered under the
U.S. Investment Company Act of 1940, and investors will not be entitled to the
benefits of such Act. Tetragon is registered in the public register of the
Netherlands Authority for the Financial Markets under Section 1:107 of the
Financial Markets Supervision Act as a collective investment scheme from a
designated country.
This information was brought to you by Cision http://news.cision.com
